Year-End Report
NOSSAMAN LLP for AMGEN INC
Firm
Client
Income
$60,000
Expenses
—
What was lobbied
2 issue areas, each in the filer's own words, with who lobbied on it and where.
Copyright/Patent/Trademark CPT
Intellectual Property and Process Patent Issues.
| Lobbyist | Covered position, as disclosed |
|---|---|
| FREDERICK T DOMBO | N/A |
| BRIAN KEITH HEARD | N/A |
| TIMOTHY W JENKINS | N/A |
| SHERRY HARPER WIDICUS | LEGISLATIVE DIRECTOR, CONGRESSMAN RON KIND |
Medicare/Medicaid MMM
Medicare Coverage and Reimbursement issues. S.J. Resolution 22 and H.J. Resolution 54, providing for Congressional Disapproval of a National Coverage Determination restricting Medicare Coverage of Erythropoiesis-Stimulating Agents (ESAs).
| Lobbyist | Covered position, as disclosed |
|---|---|
| FREDERICK T DOMBO | N/A |
| BRIAN KEITH HEARD | N/A |
| TIMOTHY W JENKINS | N/A |
| SHERRY HARPER WIDICUS | LEGISLATIVE DIRECTOR, CONGRESSMAN RON KIND |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.